Meike Heger

Elliott Advisors (UK) Ltd. (Elliott UK) is an alternative investment firm headquartered in London, UK. The firm was founded in 1994 and is a subsidiary of Elliott Management Corp., which is owned by Elliott Capital Advisors LP in the US. Elliott UK manages assets of high net worth clients.

H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany.

Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany.

Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France.

BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations.

Biom Venture Capital GmbH & Co. Fonds KG invests in early-stage companies based in the region of Bavaria in Germany focused on life sciences.

Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

Active Ownership Capital SARL operates as an investment firm. It acquires stakes in publicly listed, undervalued small, and mid-size corporations in the German and Scandinavian markets. The company was founded by Florian M. Schuhbauer and Klaus Röhrig in 2014 and is headquartered in Luxembourg.

balandis real estate AG engages in the acquisition, management, value enhancement, and sale of real estate properties. It focuses on commercial properties such as offices and retail stores. The company was founded on December 23, 2013 and is headquartered in Gräfelfing, Germany.

Munich Innovative Biomaterials GmbH functions as a pension/retirement fund. The private company is based in Munich, Germany.

3R Investments Ltd. provides financial and investment services.

White Elephant SARL provides and offers investment services. The company is headquartered in Grevenmacher, Luxembourg.

Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland.

bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany.

Part of Active Ownership Corp SARL, AOC Technology SAS is an investment holding Luxembourger company. The company is based in Luxembourg, Luxembourg.

AT Beteiligungsverwaltung GmbH provides investment management services. The private company is based in Munich, Germany. The CEOs are Wolfgang Essler, Thomas Peter Maier. The German company was founded in 2018.

Active Ownership Corp SARL provides investment advice. The private company is based in Grevenmacher, Luxembourg. and has subsidiaries in Luxembourg. The Luxembourger company was founded by Florian M. Schuhbauer, Klaus Röhrig.

LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany.